text: New Strategies to Improve Patient Adherence to Medications for Noncommunicable Diseases During and After the COVID 19 Era Identified via a Literature Review Noncommunicable diseases NCDs place a huge burden on healthcare systems and society as a whole Relatively early in the coronavirus disease 2019 COVID 19 pandemic clinicians became aware that in individuals infected with COVID 19 those with preexisting NCDs such as diabetes mellitus and cardiovascular disease CVD were at a greater risk of poor outcomes and mortality than those without The importance of adherence to medications and lifestyle changes to control and prevent NCDs has been a major focus for many years but with limited success the proportion of patients adherent and persistent to their medications remains very low There are many facets to adherence and persistence Recent evidence suggests that a patient centric approach is important and ensuring that a patient is both motivated and empowered is critical to improving adherence persistence The COVID 19 pandemic has brought many changes to the way in which patients with NCDs are managed with telemedicine and ehealth becoming more common Changes have also occurred in the way in which patients can gain access to medications during the pandemic The potential for these changes forms the basis of improving the management of patients with NCDs both during and after the pandemic Over the coming months a huge amount of work will be put into initiatives to promote adherence to COVID 19 vaccination programs Those at highest risk of severe COVID 19 such as people aged 80 years and older are likely to receive the vaccine first in some parts of world Finally social determinants of health are critical elements that can impact not just the likelihood of having an NCD or becoming infected with COVID 19 but also access to healthcare and a patients adherence and persistence with their treatments 